These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 11764539

  • 21. COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs.
    Moore BC, Simmons DL.
    Curr Med Chem; 2000 Nov; 7(11):1131-44. PubMed ID: 11032963
    [Abstract] [Full Text] [Related]

  • 22. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [Abstract] [Full Text] [Related]

  • 23. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM.
    J Environ Pathol Toxicol Oncol; 2002 Nov; 21(2):193-201. PubMed ID: 12086406
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [COX-2 expression in gastric cancers].
    Sakamoto C.
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H, Morgan G.
    Ann Chir Gynaecol; 2000 Apr; 89(3):173-6. PubMed ID: 11079784
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of cyclooxygenase inhibitors in cancer prevention.
    Anderson WF, Umar A, Viner JL, Hawk ET.
    Curr Pharm Des; 2002 Apr; 8(12):1035-62. PubMed ID: 11945150
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z, Milas L, Komaki R, Stevens C, Cox JD.
    Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
    [Abstract] [Full Text] [Related]

  • 33. Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents.
    Nardone G, Rocco A.
    Dig Dis; 2004 Aug; 22(4):320-6. PubMed ID: 15812154
    [Abstract] [Full Text] [Related]

  • 34. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer.
    Mohan S, Epstein JB.
    Oral Oncol; 2003 Sep; 39(6):537-46. PubMed ID: 12798395
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. COX-2 in large bowel cancer: a one-sided story.
    DuBOIS RN.
    Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
    [No Abstract] [Full Text] [Related]

  • 38. COX-2 inhibitors: a review.
    Houston AM, Teach SJ.
    Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.